NEW YORK, Sept. 1 /PRNewswire-FirstCall/ -- Allscripts (Nasdaq: MDRX) today will announce in a ceremony at the NASDAQ MarketSite in Times Square the completion of the ...

Hospitals and doctors are slowly -- but finally! -- getting the idea that they need to work more closely together to improve quality and cut costs. Unsurprisingly, healthcare IT -- especially ...

"With the opportunity to qualify for ARRA funding just months away, we expect that more hospitals and physicians will look to Allscripts as the Electronic Health Record company best able to connect ...

LONDON/NEW YORK (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for electronic ...

DALLAS--(BUSINESS WIRE)--ChartScout, the intuitive patient-chart search and visualization solution by Emerge Medical Data Intelligence, has been selected as the April App of the Month by global health ...

芝加哥--(BUSINESS WIRE)--(美国商业资讯)--Allscripts health care Solutions（NASDAQ: MDRX，简称“Allscripts”）今日宣布，它已通过Constellation Software Inc. (TSX:CSU)全资子公司N. Harris Computer ...

Misys Plc said it would sell its majority stake in the Allscripts health-care information business for about $1.3 billion, facilitating an all-stock merger between the unit and Eclipsys Corp. Misys ...

Allscripts CEO Glen Tullman celebrated the launch of the newly-combined company today by presiding over the NASDAQ opening bell. The merger of Allscripts with Eclipsys will help connect 180,000 ...

LONDON (MarketWatch) -- Healthcare IT company Allscripts-Misys Healthcare Solutions said Wednesday that it will buy Eclipsys Corp. in a $1.3 billion all-stock deal as it seeks to take advantage of a ...

©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR ...

"Any time a business decision is client-driven, it's much more likely to be successful," says Allscripts CEO Glen Tullman. And so, Tullman says, he has high hopes for his company's $1.3 billion dollar ...